IMVT

Insider trade Sale by Fromkin Andrew J.

3d ago

Insider trade Sale by Gloria Melanie (Chief Operating Officer)

10d ago

Scanner Large up move: 35.3% (2.7x normal daily movement)

11d ago

News Roivant gains after mid-stage trial data for Immunovant’s main asset

13d ago

Scanner Unusual buy pressure (4.7x avg, 77% up-volume, +12.5% / +3.63 intraday, above VWAP)

13d ago

News Immunovant GAAP EPS of -$0.73 misses by $0.13

13d ago

SEC filing IMVT Reports $902M Cash, $147.9M Net Loss, $0.73 EPS for Q4 FY2026

13d ago

Short volume Short volume 72% of volume (3.1σ)

13d ago

News Why Immunovant Stock Blasted Higher Today

14d ago

News Immunovant Posts 34% R&D Jump in Q1

14d ago

News IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab

14d ago

News Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study

14d ago

News Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus

14d ago

Insider trade Sale by Robert Graham Susman

31d ago

Insider trade Sale by Jay S Stout (Chief Technology Officer)

38d ago

Insider trade Sale by Tiago Girao (Chief Financial Officer)

38d ago

Insider trade Sale by Tuyl Christopher Van (Chief Legal Officer)

52d ago

Insider trade Sale by Jay S Stout (Chief Technology Officer)

52d ago

Insider trade Sale by Melanie Gloria (Chief Operating Officer)

52d ago

Insider trade Sale by Tuyl Christopher Van (Chief Legal Officer)

73d ago

Insider trade Sale by Melanie Gloria (Chief Operating Officer)

94d ago

Insider trade Sale by Jay S Stout

104d ago

News Catalyst Watch: Amazon earnings, IPO blitz, gold swings, and the jobs report

122d ago

News Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million?

165d ago

News Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million?

165d ago